Page 93 - ITPS-8-1

INNOSC Theranostics and
Pharmacological Sciences Brain glutamate level after treatment with NAC

families/ocd/what-is-obsessive-compulsivedisorder [Last Diagnosis and management. Am Fam Physician.
accessed on 2023 Nov 20]. 2015;92(10):896-903.
2. Adam Y, Meinlschmidt G, Gloster AT, Lieb R. Obsessive- 13. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice
compulsive disorder in the community: 12-month guidelines for the management of anxiety, posttraumatic
prevalence, comorbidity and impairment. Soc Psychiatry stress and obsessive-compulsive disorders. BMC Psychiatry.
Psychiatr Epidemiol. 2012;47(3):339-349. 2014;14:S1.
doi: 10.1007/s00127-010-0337-5 doi: 10.1186/1471-244X-14-S1-S1
3. Solish AJ. Parents’ Involvement in Behavioural Intervention 14. Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ.
for their Children with Autism. Vol. 73. Canada: York World Federation of Societies of Biological Psychiatry
University; 2010. p. 632. (WFSBP) guidelines for the pharmacological treatment
4. Algin S, Sajib MW, Arafat SY. Demography and symptom of anxiety, obsessive-compulsive and post-traumatic
severity of obsessive compulsive disorder in Bangladesh: stress disorders - first revision. World J Biol Psychiatry.
A cross-sectional observation. Bangladesh J Psychiatry. 2008;9(4):248-312.
2016;30(2):23-26. doi: 10.1080/15622970802465807
doi: 10.3329/bjpsy.v30i2.45360 15. Swierkosz-Lenart K, Dos Santos JFA, Elowe J, et al. Therapies
5. World Health Organization (WHO). The Global Burden of for obsessive-compulsive disorder: Current state of the
Disease. World Health Organization; 2018. Available from: art and perspectives for approaching treatment-resistant
https://www.ocduk.org/ocd/world-health-organisation patients. Front Psychiatry. 2023;14:1065812.
[Last accessed on 2023 Nov 26]. doi: 10.3389/fpsyt.2023.1065812
6. Meier SM, Mattheisen M, Mors O, Schendel DE, 16. Janardhan Reddy YC, Sundar AS, Narayanaswamy JC,
Mortensen PB, Plessen KJ. Mortality among persons Math SB. Clinical practice guidelines for obsessive-compulsive
with obsessive-compulsive disorder in denmark. JAMA disorder. Indian J Psychiatry. 2017;59(Suppl 1):S74-S90.
Psychiatry. 2016;73(3):268-274.
doi: 10.4103/0019-5545.196976
doi: 10.1001/jamapsychiatry.2015.3105
17. Pittenger C, Bloch MH. Pharmacological treatment of
7. Norberg MM, Calamari JE, Cohen RJ, Riemann BC. Quality obsessive-compulsive disorder. Psychiatr Clin North Am.
of life in obsessive-compulsive disorder: An evaluation of 2014;37(3):375-391.
impairment and a preliminary analysis of the ameliorating
effects of treatment. Depress Anxiety. 2008;25(3):248-259. doi: 10.1016/j.psc.2014.05.006
doi: 10.1002/da.20298 18. Pallanti S, Grassi G, Cantisani A. Emerging drugs to treat
obsessive-compulsive disorder. Expert Opin Emerg Drugs.
8. American Psychiatric Association: Washington, DC. 2014;19(1):67-77.
Diagnostic and Statistical Manual of Mental Disorders
(DSM-5). 5 ed. Washington, DC: American Psychiatric doi: 10.1517/14728214.2014.875157
th
Association; 2013. Available from: https://www.ocduk. 19. Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-
org/ocd/clinical-classification-of/ocd/dsm-and/ocd [Last compulsive disorder: Advances in diagnosis and treatment.
accessed on 2021 Nov 25]. JAMA. 2017;317(13):1358-1367.
9. Zhang H, Wang B, Li K, et al. Altered functional connectivity doi: 10.1001/jama.2017.2200
between the cerebellum and the cortico-striato-thalamo-
cortical circuit in obsessive-compulsive disorder. Front 20. Bloch MH, McGuire J, Landeros-Weisenberger A,
Psychiatry. 2019;10:522. Leckman JF, Pittenger C. Meta-analysis of the dose-response
relationship of SSRI in obsessive-compulsive disorder. Mol
doi: 10.3389/fpsyt.2019.00522 Psychiatry. 2010;15(8):850-855.
10. Kariuki-Nyuthe C, Gomez-Mancilla B, Stein DJ. Obsessive doi: 10.1038/mp.2009.50
compulsive disorder and the glutamatergic system. Curr
Opin Psychiatry. 2014;27(1):32-37. 21. Bandelow B. The medical treatment of obsessive-compulsive
disorder and anxiety. CNS Spectr. 2008;13(9 Suppl 14):37-46.
doi: 10.1097/YCO.0000000000000017
doi: 10.1017/s1092852900026924
11. Berk M, Ng F, Dean O, Dodd S, Bush AI. Glutathione:
A novel treatment target in psychiatry. Trends Pharmacol 22. Bakizadeh F, Mokhtari S, Saeed F, Mokhtari A, Akbari
Sci. 2008;29(7):346-351. Koli P, Shalbafan M. Cognitive rehabilitation for adult
patients with obsessive-compulsive disorder: A systematic
doi: 10.1016/j.tips.2008.05.001
review of randomized controlled trials. Basic Clin Neurosci.
12. Fenske JN, Petersen K. Obsessive-compulsive disorder: 2024;15(3):287-300.

Volume 8 Issue 1 (2025) 87 doi: 10.36922/itps.4887